-
Je něco špatně v tomto záznamu ?
Validation Study of a German Cognitive Battery for Huntington's Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease Burden
A. Mühlbäck, W. Frank, O. Klempířová, O. Bezdíček, L. Schmitt, N. Hofstetter, GB. Landwehrmeyer, J. Klempíř
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
PubMed
32613239
DOI
10.1093/arclin/acaa038
Knihovny.cz E-zdroje
- MeSH
- Huntingtonova nemoc * komplikace diagnóza MeSH
- kognice MeSH
- lidé MeSH
- neuropsychologické testy MeSH
- osobní újma zaviněná nemocí MeSH
- tělesná a funkční výkonnost MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: Cognitive decline is a key characteristic of Huntington's disease (HD). This study aimed to investigate the diagnostic accuracy of a cognitive battery with six tests used by most HD research centers to assess cognitive impairment in HD. METHOD: In total, 106 HD patients in different disease stages with more (HD-CD, N = 30) and less cognitive impairments (HD-NC, N = 70) and 100 healthy controls (NC) were matched by age, sex, and education and were examined using a standardized protocol including cognitive, motor, and functional assessments. RESULTS: One-way between-groups analysis of variance showed that controls performed significantly better than HD patients and that HD-NC significantly outperformed HD-CD patients in all cognitive tests (NC > HD-NC > HD-CD), with all Games-Howell post-hoc tests p < .001. Analyses using area under the receiver-operating characteristic curve (AUC) disclosed the diagnostic accuracy of all tests included in the battery to discriminate between NC and HD patients with AUC ranging from 0.809 to 0.862 (all p < .001) and between HD-CD and HD-NC patients with AUC ranging from 0.833 to 0.899 (all p < .001). In both analysis, Stroop Color Naming Test showed the highest discriminative potential. Additional analyses showed that cognitive deficits in all domains progressed with disease duration. Moreover, cognitive performance correlated with the severity of motor and functional impairment (all p < .001) and with the Disease Burden Score regardless of disease duration and age. CONCLUSION: Our results indicate that the cognitive battery is a suitable tool for assessing cognitive impairment in HD.
Department of Interdisciplinary Pain Therapy Day Clinic Klinikum Erding Erding Germany
Department of Neurology University Hospital of Ulm Ulm Germany
Department of Neuropsychiatry Huntington Center South kbo Isar Amper Klinikum Taufkirchen Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011593
- 003
- CZ-PrNML
- 005
- 20210507101607.0
- 007
- ta
- 008
- 210420s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/arclin/acaa038 $2 doi
- 035 __
- $a (PubMed)32613239
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mühlbäck, Alžbeta $u Department of Neuropsychiatry, Huntington Center South, kbo-Isar-Amper-Klinikum, Taufkirchen (Vils), Germany $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $u Department of Neurology, University Hospital of Ulm, Ulm, Germany
- 245 10
- $a Validation Study of a German Cognitive Battery for Huntington's Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease Burden / $c A. Mühlbäck, W. Frank, O. Klempířová, O. Bezdíček, L. Schmitt, N. Hofstetter, GB. Landwehrmeyer, J. Klempíř
- 520 9_
- $a OBJECTIVE: Cognitive decline is a key characteristic of Huntington's disease (HD). This study aimed to investigate the diagnostic accuracy of a cognitive battery with six tests used by most HD research centers to assess cognitive impairment in HD. METHOD: In total, 106 HD patients in different disease stages with more (HD-CD, N = 30) and less cognitive impairments (HD-NC, N = 70) and 100 healthy controls (NC) were matched by age, sex, and education and were examined using a standardized protocol including cognitive, motor, and functional assessments. RESULTS: One-way between-groups analysis of variance showed that controls performed significantly better than HD patients and that HD-NC significantly outperformed HD-CD patients in all cognitive tests (NC > HD-NC > HD-CD), with all Games-Howell post-hoc tests p < .001. Analyses using area under the receiver-operating characteristic curve (AUC) disclosed the diagnostic accuracy of all tests included in the battery to discriminate between NC and HD patients with AUC ranging from 0.809 to 0.862 (all p < .001) and between HD-CD and HD-NC patients with AUC ranging from 0.833 to 0.899 (all p < .001). In both analysis, Stroop Color Naming Test showed the highest discriminative potential. Additional analyses showed that cognitive deficits in all domains progressed with disease duration. Moreover, cognitive performance correlated with the severity of motor and functional impairment (all p < .001) and with the Disease Burden Score regardless of disease duration and age. CONCLUSION: Our results indicate that the cognitive battery is a suitable tool for assessing cognitive impairment in HD.
- 650 _2
- $a kognice $7 D003071
- 650 _2
- $a osobní újma zaviněná nemocí $7 D017281
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Huntingtonova nemoc $x komplikace $x diagnóza $7 D006816
- 650 _2
- $a neuropsychologické testy $7 D009483
- 650 _2
- $a tělesná a funkční výkonnost $7 D000076604
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Frank, Wiebke $u Department of Neurology, University Hospital of Ulm, Ulm, Germany
- 700 1_
- $a Klempířová, Olga $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Bezdíček, Ondřej $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Schmitt, Lena $u Department of Neuropsychiatry, Huntington Center South, kbo-Isar-Amper-Klinikum, Taufkirchen (Vils), Germany
- 700 1_
- $a Hofstetter, Nina $u Department of Interdisciplinary Pain Therapy, Day Clinic, Klinikum Erding, Erding, Germany
- 700 1_
- $a Landwehrmeyer, G Bernhard $u Department of Neurology, University Hospital of Ulm, Ulm, Germany
- 700 1_
- $a Klempíř, Jiří $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 773 0_
- $w MED00008570 $t Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists $x 1873-5843 $g Roč. 36, č. 1 (2021), s. 74-86
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32613239 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507101607 $b ABA008
- 999 __
- $a ok $b bmc $g 1650076 $s 1131972
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 36 $c 1 $d 74-86 $e 2021Jan15 $i 1873-5843 $m Archives of clinical neuropsychology $n Arch Clin Neuropsychol $x MED00008570
- LZP __
- $a Pubmed-20210420
